Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
Launched by UNIVERSITY OF UTAH · Jul 1, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people with certain types of cancer quit smoking. The study focuses on a short self-help program designed to boost motivation to stop smoking, specifically tailored for individuals diagnosed with breast, colorectal, gynecological, skin melanoma, or bladder cancer within the last six months. Researchers want to see if this program is easy to use and if participants find it helpful.
To participate, you need to be at least 18 years old, a smoker who has had at least one cigarette in the past 30 days, and able to read and write in English. You should not be currently enrolled in another smoking cessation program. If you qualify, you can expect to engage with the self-help intervention and share your feedback on it. This study is open to all genders, but male patients diagnosed with breast cancer will not be included due to the low risk of breast cancer in men.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals who smoke and recently (i.e., within 6 months) received a diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer (n = 20 per cancer type). (Investigators will consider smokers individuals who report having smoked ≥1 cigarette in the past 30 days.)
- • Able to read/write English;
- • Able to give informed consent;
- • Not currently enrolled in a smoking cessation program;
- • Age ≥18 years old.
- Exclusion Criteria:
- • Male patients diagnosed with breast cancer will be excluded as lifetime risk for breast cancer in men is far below 1%
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Ursula Martinez, PhD
Principal Investigator
Huntsman Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported